Plastoform able to operate as going concern, company tells SGX

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Plastoform able to operate as going concern, company tells SGX.

AUDIO-SPEAKER maker Plastoform Holdings' board said on Wednesday it believes that the company will be able to operate as a going concern and is in discussions about fundraising options, including a rights issue exercise, to obtain additional funding for working capital needs.It added that the firm will also borrow money if needed. The company also said it believes its licence business with Monster Inc will possibly lead to more product types and brands to the market in the future.

Plastoform was responding to Singapore Exchange's queries regarding its financials. It noted that the company is in a negative equity position of HK$0.89 million and has negative working capital of HK$1.35 million as at Dec 31, and has generated negative cash flow from operating activities of HK$1.87 million.It added:"The company still runs the original design manufacturing business and has also started new brand licencing sales with Monster logo with commencement in late-2018.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in MY
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »